RME Stock Overview
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
ResMed Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$200.28 |
| 52 Week High | US$0 |
| 52 Week Low | US$0 |
| Beta | 0.67 |
| 1 Month Change | 9.44% |
| 3 Month Change | 13.44% |
| 1 Year Change | -6.98% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -7.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| RME | BG Medical Equipment | BG Market | |
|---|---|---|---|
| 7D | 16.0% | -1.3% | 0.6% |
| 1Y | -7.0% | -0.5% | 17.1% |
Return vs Industry: RME underperformed the BG Medical Equipment industry which returned 1% over the past year.
Return vs Market: RME underperformed the BG Market which returned 17.2% over the past year.
Price Volatility
| RME volatility | |
|---|---|
| RME Average Weekly Movement | 5.7% |
| Medical Equipment Industry Average Movement | 5.9% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in BG Market | 8.2% |
| 10% least volatile stocks in BG Market | 2.4% |
Stable Share Price: RME has not had significant price volatility in the past 3 months.
Volatility Over Time: RME's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 10,140 | Mick Farrell | www.resmed.com |
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes.
ResMed Inc. Fundamentals Summary
| RME fundamental statistics | |
|---|---|
| Market cap | €29.47b |
| Earnings (TTM) | €898.29m |
| Revenue (TTM) | €4.30b |
32.8x
P/E Ratio6.9x
P/S RatioIs RME overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| RME income statement (TTM) | |
|---|---|
| Revenue | US$4.58b |
| Cost of Revenue | US$1.99b |
| Gross Profit | US$2.59b |
| Other Expenses | US$1.63b |
| Earnings | US$958.38m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.52 |
| Gross Margin | 56.51% |
| Net Profit Margin | 20.91% |
| Debt/Equity Ratio | 21.7% |
How did RME perform over the long term?
See historical performance and comparison